IRIS
GAETA, Giovanni Battista
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.547
NA - Nord America 7.693
AS - Asia 5.611
SA - Sud America 1.079
Continente sconosciuto - Info sul continente non disponibili 306
AF - Africa 86
OC - Oceania 10
Totale 29.332
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 8.990
US - Stati Uniti d'America 7.526
SG - Singapore 2.064
IE - Irlanda 1.789
CN - Cina 1.319
HK - Hong Kong 1.026
UA - Ucraina 977
BR - Brasile 914
GB - Regno Unito 800
DE - Germania 544
VN - Vietnam 472
IT - Italia 381
SE - Svezia 292
FI - Finlandia 279
GR - Grecia 175
IN - India 166
TR - Turchia 150
FR - Francia 137
KR - Corea 101
CA - Canada 83
AR - Argentina 67
BD - Bangladesh 65
JP - Giappone 65
BE - Belgio 35
MX - Messico 31
CZ - Repubblica Ceca 30
IQ - Iraq 30
ID - Indonesia 28
AT - Austria 23
EC - Ecuador 22
IR - Iran 22
NL - Olanda 22
PL - Polonia 21
PY - Paraguay 19
PK - Pakistan 18
ZA - Sudafrica 17
EU - Europa 15
VE - Venezuela 15
EG - Egitto 14
MA - Marocco 13
CO - Colombia 12
JM - Giamaica 11
TW - Taiwan 11
CL - Cile 9
TH - Thailandia 9
AU - Australia 8
DO - Repubblica Dominicana 8
PE - Perù 8
UZ - Uzbekistan 8
DZ - Algeria 7
ES - Italia 7
ET - Etiopia 7
PH - Filippine 7
TT - Trinidad e Tobago 7
UY - Uruguay 7
AZ - Azerbaigian 6
BO - Bolivia 6
CH - Svizzera 6
HN - Honduras 6
NI - Nicaragua 6
RO - Romania 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
JO - Giordania 5
GH - Ghana 4
NP - Nepal 4
BB - Barbados 3
BG - Bulgaria 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
HU - Ungheria 3
IL - Israele 3
KE - Kenya 3
KG - Kirghizistan 3
LB - Libano 3
LT - Lituania 3
MD - Moldavia 3
MY - Malesia 3
OM - Oman 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
AL - Albania 2
AP - ???statistics.table.value.countryCode.AP??? 2
BF - Burkina Faso 2
CY - Cipro 2
EE - Estonia 2
GT - Guatemala 2
LV - Lettonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
SC - Seychelles 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
Totale 29.026
Salva come PNG Salva come JPEG
Città #
Moscow 3.225
Dublin 1.783
Jacksonville 1.404
Hong Kong 1.017
Chandler 894
Singapore 743
Santa Clara 734
San Jose 558
Ashburn 336
Dallas 312
Princeton 271
Medford 236
Beijing 184
Ho Chi Minh City 161
Boardman 158
Roxbury 140
San Mateo 130
Wilmington 123
Ann Arbor 108
Hanoi 105
Hefei 105
Seoul 99
Bengaluru 97
New York 90
The Dalles 86
Woodbridge 84
Munich 79
Bremen 77
Cambridge 72
São Paulo 65
Nanjing 61
Des Moines 55
Los Angeles 55
Düsseldorf 47
Helsinki 47
Mountain View 40
Jinan 36
Brussels 34
Orem 33
Caserta 30
Rome 29
Brno 27
Nanchang 27
Rio de Janeiro 27
Venice 27
Da Nang 25
Haiphong 25
Memphis 25
Napoli 25
Zhengzhou 25
Shanghai 24
Belo Horizonte 22
Guangzhou 22
Milan 22
Norwalk 22
Shenyang 22
Atlanta 20
Naples 20
Changsha 18
Nuremberg 18
Tianjin 18
Turku 18
Campinas 17
Chennai 17
Curitiba 17
Kunming 17
Brasília 16
Porto Alegre 16
Frankfurt am Main 14
Hangzhou 14
Houston 14
Tokyo 14
Ningbo 12
Ninh Bình 12
Baghdad 11
Dhaka 11
Ottawa 11
Recife 11
Redwood City 11
Santo André 11
Guayaquil 10
Haikou 10
Hebei 10
Hải Dương 10
Toronto 10
Asunción 9
Auburn Hills 9
Istanbul 9
Kraków 9
Padova 9
Shenzhen 9
Biên Hòa 8
Chicago 8
Council Bluffs 8
Kingston 8
Lanzhou 8
Manaus 8
Pittsburgh 8
Taizhou 8
Tashkent 8
Totale 14.844
Salva come PNG Salva come JPEG
Nome #
1) Analisi delle discontinuità di distribuzione e dei tempi di accumulo di radiocolloide in epatopatici cronici: risultati preliminari 475
A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients 347
Detection of in vivo hepatitis B virus surface antigen mutations-A comparison of four routine screening assays 306
ANTI TNF ALFA IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE E SPONDILOARTRITI HBV CARRIERS OCCULTI:STUDIO RETROSPETTIVO SULLA SICUREZZA 304
ANTI-TNFα TREATMENT IS ASSOCIATED WITH INCREASED LIVER STIFFNESS IN HBV OCCULT CARRIER PATIENTS 188
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology. 180
Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life 178
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 168
Active recruitment strategy in disadvantaged immigrant populations improves the identification of human immunodeficiency but not of hepatitis B or C virus infections 168
3. HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years. 166
AISF position paper on HCV in immunocompromised patients 166
Ittero in corso di infezione delle vie urinarie. Presentazione di un caso clinico ed aspetti patogenetici 160
Changing aetiological factors of hepatocellular carcinoma and their potential impact on the effectiveness of surveillance 157
Patologie virali tropicali (Flavivirus, Filovirus, Arenavirus, Bunyavirus, Togavirus: Chikungunya, 157
AISF position paper on liver disease and pregnancy 153
Bacterial pneumonia in patients with liver cirrhosis, with or without HIV co-infection: a possible definition of antibiotic prophylaxis associated pneumonia (APAP) 152
Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy. 152
Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania 152
[Elevata prevalenza ma bassa incidenza della infezione da HGV in pazienti con epatite cronica C] 150
Adefovir dipivoxil-associated thrombocytopenia in a patient with chronic hepatitis B 148
Declining prevalence and increasing awareness of HCV infection in Italy: A population-based survey in five metropolitan areas 147
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 146
Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide Analogues. 144
[Prevalence and risk factors for bacteriuria in patients with cirrhosis] 144
A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy 143
Endotoxin protects against chlorpromazine-induced cholestasis in the isolated perfused rat liver 142
Changing indications for liver transplant: slow decline of hepatitis viruses in Italy 142
Recommendations for the management of acute hepatitis B: position paper of the italian Society for the study of infectious and tropical diseases 141
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 141
Absence of mutations in the YMDD motif/B region of the hepatitis B polymerase in famciclovir therapy failure 140
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 139
[Spontaneous bacterial peritonitis in patients with liver cirrhosis. Differential aspects with portal thrombosis] 138
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 137
Virological patterns of HCV patients with failure to interferon-free regimens. 137
Survival after locoregional treatments for hepatocellular carcinoma: a cohort study in real-world patients. 135
[Cutaneous myiasis from Cordylobia anthropophaga in a traveller returning from Senegal: a case study] 135
Clinical and histological aspects of chronic HCV infection and cirrhosis 134
Different changes in mitochondrial apoptotic pathway in lymphocytes and granulocytes in cirrhotic patients with sepsis. 132
Effect of prednisone priming followed by alpha-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial 131
Prolonged treatment of children with chronic hepatitis B with recombinant alpha 2a-interferon: a controlled, randomized study 131
AASLD Practice Guidelines on chronic hepatitis B and HBV infection in Italy 131
Treatment of chronic hepatitis B in children with prednisone followed by alpha-interferon: a controlled randomized study 130
Influenza vaccination in patients with cirrhosis and in liver transplant recipients 130
Combination of Tenofovir Disoproxil Fumarate and Peginterferon alfa-2a Increases Loss of Hepatitis B Surface Antigen in Patients with Chronic Hepatitis B 130
Effect of endotoxin tolerance on drug hepatotoxicity: amelioration of taurolithocholate cholestasis in the perfused rat liver 129
Liver's functional alterations produced from erythromycin estolate in the isolated and perfused rat liver 129
Baseline HBV-DNA level is an important predictor of response to interferon in children with chronic hepatitis B 129
Absence of mutations in the YMDD motif/B region of the hepatitis B virus polymerase in famciclovir therapy failure 128
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy. 128
A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3 127
Clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long-term tenofovir or entecavir 127
Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta 126
Hepatitis delta infection in Italian patients: towards the end of the story? 126
Fattori di rischio per l'infezione tifoidea nell'area geografica del golfo di Napoli 125
[Visceral leishmaniasis: its epidemiology, clinical picture and therapy] 125
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study 125
Bacterial endotoxin effect on liver plasma membranes (LPM): membrane-bound enzymes as probes of the site of interaction 124
Effect of pretreatment with bacterial endotoxin on erythromycin estolate-induced cholestasis 123
[Visceral leishmaniasis in Italy. Its epidemiology, clinical picture and therapy] 123
[Cryptosporidium infection in immunocompetent and immunocompromised host] 123
Effects of bacterial lipopolysaccharide (LPS) on chlorpromazine (CPZ) induced cholestasis in the isolated perfused rat liver 123
Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP) 122
Prevention of the toxicity of erythromycin estolate in the perfused rat liver by endotoxin 122
Liver toxicity during copper chronic intoxication in rats 122
Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma. A Cancer of the Liver Italian Program (CLIP 08)retrospective case-control study 121
The homeostasis model assessment of insulin resistance score is not predictive of sustained virologic response in chronic hepatiti s C patients 121
Amphotericin B-induced depression in the phagocytic function of the isolated rat liver and its prevention by nifedipine 121
Doctors in the kitchen. Experiments with cooking bivalve mollusks 120
Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial 120
Fever of unknown origin: a systematic review of the literature for 1995-2004 120
Effetto della eritromicina sulle funzioni escretorie del fegato di ratto isolato 120
Archi-Prevaleat Project. A National Register of Color-Doppler Ultrasonography of the Epi-Aortic Vessels in Patients Living with HIV. 120
Influence of tauroursodeoxycholic and taurodeoxycholic acids on hepatic metabolism and biliary secretion of phosphatidylcholine in the isolated rat liver 119
Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER cohort study (PLoS ONE (2017) 12: 2 (e0172159) DOI: 10.1371/journal.pone.0172159) 119
Cholestasis induced by estradiol-17 beta-D-glucuronide: mechanisms and prevention by sodium taurocholate 118
Functional changes induced by taurolithocolic acid in the isolated perfused rat liver 118
Bacterial endotoxin treatment ameliorates erythromycin estolate-induced cholestasis in the isolated perfused rat liver 118
Pretreatment of isolated rat hepatocytes with endotoxin decreases erythromicin estolate - induced aspartate transaminase release 118
Discriminating value of serum bile acids in asymptomatic HBsAg carriers 118
Reactivation of hepatitis B virus in cancer patients treated with chemotherapy for solid tumors. Is the prophylaxis really required? 118
Efficacy of amphotericin B colloidal dispersion in the treatment of Mediterranean visceral leishmaniasis in immunocompetent adult patients 117
Chronic endotoxin pretreatment protects from the chlorpromazine induced cholestasis 117
Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study 116
Hepatic excretory function in the endotoxin tolerant rat 116
The effect of an antimicrobial stewardship programme in two intensive care units of a teaching hospital: an interrupted time series analysis 116
Anti-hepatitis A virus seroprevalence and seroconversion in a cohort of patients with chronic viral hepatitis 115
Endotoxin reduces erythromycine estolate-induced releas of aspartate transaminase from isolated rat liver cells 115
Severe polymyositis due to Toxoplasma gondii in an adult immunocompetent patient: a case report and review of the literature. 115
Increased liver stiffness in idiopathic pulmonary fibrosis: a pilot study 115
Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort 115
Cholestatic effect of amphotericin B on the isolated perfused rat liver. Preliminary study 114
Estradiol-17 beta-D-glucuronide (E-17G) cholestasis in perfused rat liver: fate of E-17G and choleretic responses to bile salts 112
Interference of endotoxin pretreatment on the taurolithocholate induced cholestasis 112
Hepatitis C virus infection in Italy: a multicentric sero-epidemiological study. (A report from the HCV study group of the Italian Association for the study of the liver) 111
Virological profiles in hepatitis B virus/hepatitis C virus coinfected patients under interferon plus ribavirin therapy 111
Effect of chronic copper administration on excretory function of rat liver 111
The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients 110
Prospective Validation of the CLIP Score: A New Prognostic System for Patients With Cirrhosis and Hepatocellular Carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators 110
Factors associated with access to antiviral treatment in a multicentre cross-sectional study of patients with chronic hepatitis B in Italy. 109
The role of surgery in transmitting "post-transfusion" hepatitis 109
Totale 14.008
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.426
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.426
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.542 0 11 17 62 590 14 30 65 70 97 132 454
2022/20233.346 293 45 38 302 311 286 6 216 1.694 26 56 73
2023/20241.143 113 34 51 110 438 75 10 35 4 25 57 191
2024/20253.550 58 53 34 102 502 309 582 308 526 622 263 191
2025/202614.292 407 516 929 762 1.133 8.376 689 351 552 268 204 105
2026/2027336 99 237 0 0 0 0 0 0 0 0 0 0
Totale 29.332